Clinical Trial Update: Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating a docetaxel/cisplatin/fluorouracil regimen for previously untreated Stage II-IV nasal cavity and paranasal sinus cancers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Cavity Cancer
• Paranasal Sinus Cancer
• Sinonasal Squamous Cell Carcinoma
• Sinonasal Undifferentiated Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING